1. Home
  2. GKOS vs ASLE Comparison

GKOS vs ASLE Comparison

Compare GKOS & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • ASLE
  • Stock Information
  • Founded
  • GKOS 1998
  • ASLE 2008
  • Country
  • GKOS United States
  • ASLE United States
  • Employees
  • GKOS N/A
  • ASLE N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • ASLE Industrial Specialties
  • Sector
  • GKOS Health Care
  • ASLE Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • ASLE Nasdaq
  • Market Cap
  • GKOS 5.1B
  • ASLE 322.4M
  • IPO Year
  • GKOS 2015
  • ASLE N/A
  • Fundamental
  • Price
  • GKOS $90.52
  • ASLE $6.16
  • Analyst Decision
  • GKOS Strong Buy
  • ASLE Strong Buy
  • Analyst Count
  • GKOS 13
  • ASLE 3
  • Target Price
  • GKOS $135.15
  • ASLE $8.67
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • ASLE 446.1K
  • Earning Date
  • GKOS 04-30-2025
  • ASLE 05-07-2025
  • Dividend Yield
  • GKOS N/A
  • ASLE N/A
  • EPS Growth
  • GKOS N/A
  • ASLE N/A
  • EPS
  • GKOS N/A
  • ASLE N/A
  • Revenue
  • GKOS $404,523,000.00
  • ASLE $320,302,000.00
  • Revenue This Year
  • GKOS $27.84
  • ASLE $14.51
  • Revenue Next Year
  • GKOS $27.88
  • ASLE $18.41
  • P/E Ratio
  • GKOS N/A
  • ASLE N/A
  • Revenue Growth
  • GKOS 23.92
  • ASLE N/A
  • 52 Week Low
  • GKOS $77.10
  • ASLE $4.53
  • 52 Week High
  • GKOS $163.71
  • ASLE $9.40
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 46.57
  • ASLE 33.59
  • Support Level
  • GKOS $84.26
  • ASLE $6.84
  • Resistance Level
  • GKOS $89.62
  • ASLE $7.18
  • Average True Range (ATR)
  • GKOS 3.97
  • ASLE 0.29
  • MACD
  • GKOS 0.49
  • ASLE 0.01
  • Stochastic Oscillator
  • GKOS 61.67
  • ASLE 28.57

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ASLE AerSale Corporation

AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.

Share on Social Networks: